Pharmacodynamic interaction between midazolam and a specific benzodiazepine antagonist in humans.
about
Possible interaction of fluoroquinolones with the benzodiazepine-GABAA-receptor complex.Lack of effect of nitrendipine on the pharmacokinetics and pharmacodynamics of midazolam during steady stateFlumazenil in benzodiazepine antagonism. Actions and clinical use in intoxications and anaesthesiology.Clinical neuropharmacology of drugs of abuse: a comparison of drug-discrimination and subject-report measures.Flumazenil reversal of conscious sedation induced with intravenous fentanyl and diazepam.Reversal of central benzodiazepine effects by intravenous flumazenil.Benzodiazepines.Reversal agents in sedation and anesthesia: a review.Fibreoptic intubation and bronchofibrescopy in anaesthesia and intensive care.Does the benzodiazepine antagonist Ro 15-1788 antagonize the action of ethanol?The effect of intravenous administration of variable-dose flumazenil after fixed-dose ketamine and midazolam in healthy cats.A randomised crossover trial of post-operative cognitive and psychomotor recovery from benzodiazepine sedation: effects of reversal with flumazenil over a prolonged recovery period.Flumazenil exerts intrinsic activity on sleep EEG and nocturnal hormone secretion in normal controls.An assessment of resedation following flumazenil-induced antagonism of intravenous midazolam: comparison of psychomotor and amnesic recovery with a non-sedated reference group.Intraocular pressure in anaesthetized dogs given flumazenil with and without prior administration of midazolam.Postoperative analgesic requirements following flumazenil administration.Effects of the benzodiazepine antagonist flumazenil on postoperative performance following total intravenous anaesthesia with midazolam and alfentanil.
P2860
Q24538958-18A861C2-BE2F-47E2-9585-20972646034CQ34417679-2BB4A341-E4B1-4D9E-A3D4-713B81B53B5FQ34683141-BA9AE738-8C6C-44D1-A6D2-E8702E33D361Q35684589-95117530-E27C-4364-913E-125DC0AF367EQ36289846-BEC89E2F-8630-4025-A5FA-999EB26BE0A7Q36308705-DCA27BF1-0129-4AC3-9BEE-1533D4D7B357Q39180030-B273D1CB-46E6-4024-8291-E955F4ACA76AQ39605060-F8E4DA91-28AD-4489-B8B3-1CB876131002Q40510888-5B553F40-25D3-4C4C-8500-6C3E3CE14092Q43094429-E271A79A-DE2D-4BFB-B4DB-42654DE689DBQ44039671-BFE9D7D7-B88B-428F-BC01-C3A4D3DD3756Q45155367-DF3B4810-4B20-4412-B131-F9BAC98D7740Q48855529-E0590226-ABFE-41DE-812A-9B3C0782D9AAQ51612879-46F397B7-77D4-4253-BDB8-4D87C398728DQ51713658-AE5D0B90-4FAB-45E9-9E9E-664917993857Q51723522-4E3B50B2-14A7-499B-896B-0762F301A80DQ51769486-B0E1324C-4B1D-449B-9011-7396483FE80D
P2860
Pharmacodynamic interaction between midazolam and a specific benzodiazepine antagonist in humans.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
Pharmacodynamic interaction be ...... iazepine antagonist in humans.
@en
Pharmacodynamic interaction be ...... iazepine antagonist in humans.
@nl
type
label
Pharmacodynamic interaction be ...... iazepine antagonist in humans.
@en
Pharmacodynamic interaction be ...... iazepine antagonist in humans.
@nl
prefLabel
Pharmacodynamic interaction be ...... iazepine antagonist in humans.
@en
Pharmacodynamic interaction be ...... iazepine antagonist in humans.
@nl
P2093
P2860
P1476
Pharmacodynamic interaction be ...... iazepine antagonist in humans.
@en
P2093
P2860
P304
P356
10.1002/J.1552-4604.1985.TB02866.X
P577
1985-09-01T00:00:00Z